)
)
ImmunoPrecise Antibodies Investor Relations Material
Latest events
Q2 2025
ImmunoPrecise Antibodies
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from ImmunoPrecise Antibodies Ltd
Access all reports
Segment Data
Access more data
Revenue by
Geography
Europe
U.S.
Australia
Canada
Other
Expenses by
Financials
ImmunoPrecise Antibodies Ltd. engages in antibody production and related services worldwide. It offers purification and affinity maturation of monoclonal antibodies; design, development, and validation of comprehensive service packages for the discovery of novel antibodies against therapeutic targets; custom peptide synthesis services; recombinant protein expression platforms; custom vaccines and neutralizing antibodies for passive transfer applications; and an in vivo passive transfer model for assessing the efficacy of passive immune treatments targeting infectious diseases.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
IPA
Country
🇺🇸 United States